Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas

被引:135
作者
Zhou, Hao [1 ]
Chang, Ken [3 ]
Bai, Harrison X. [5 ]
Xiao, Bo [1 ]
Su, Chang [7 ]
Bi, Wenya Linda [9 ]
Zhang, Paul J. [6 ]
Senders, Joeky T. [10 ]
Vallieres, Martin [8 ]
Kavouridis, Vasileios K. [10 ]
Boaro, Alessandro [10 ]
Arnaout, Omar [10 ]
Yang, Li [4 ]
Huang, Raymond Y. [2 ]
机构
[1] Cent South Univ, Dept Neurol, Xiangya Hosp, Changsha, Hunan, Peoples R China
[2] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02215 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02115 USA
[4] Cent South Univ, Xiangya Hosp 2, Dept Neurol, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China
[5] Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
[6] Hosp Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[7] Yale Sch Med, New Haven, CT 06510 USA
[8] McGill Univ, Med Phys Unit, Montreal, PQ, Canada
[9] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Ctr Skull Base & Pituitary Surg, Boston, MA 02215 USA
[10] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Computat Neurosci Outcomes Ctr, Boston, MA 02215 USA
基金
中国国家自然科学基金; 美国国家卫生研究院;
关键词
Glioma; Isocitrate dehydrogenase (IDH); 1p19q codeletion; Machine learning; Random forest; MRI; OLIGODENDROGLIAL TUMORS; GENOMIC ANALYSIS; LONGER SURVIVAL; MUTATION STATUS; IDH1; CLASSIFICATION; 2-HYDROXYGLUTARATE; SPECTROSCOPY; TEMOZOLOMIDE; SIGNATURES;
D O I
10.1007/s11060-019-03096-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
PurposeIsocitrate dehydrogenase (IDH) and 1p19q codeletion status are importantin providing prognostic information as well as prediction of treatment response in gliomas. Accurate determination of the IDH mutation status and 1p19q co-deletion prior to surgery may complement invasive tissue sampling and guide treatment decisions.MethodsPreoperative MRIs of 538 glioma patients from three institutions were used as a training cohort. Histogram, shape, and texture features were extracted from preoperative MRIs of T1 contrast enhanced and T2-FLAIR sequences. The extracted features were then integrated with age using a random forest algorithm to generate a model predictive of IDH mutation status and 1p19q codeletion. The model was then validated using MRIs from glioma patients in the Cancer Imaging Archive.ResultsOur model predictive of IDH achieved an area under the receiver operating characteristic curve (AUC) of 0.921 in the training cohort and 0.919 in the validation cohort. Age offered the highest predictive value, followed by shape features. Based on the top 15 features, the AUC was 0.917 and 0.916 for the training and validation cohort, respectively. The overall accuracy for 3 group prediction (IDH-wild type, IDH-mutant and 1p19q co-deletion, IDH-mutant and 1p19q non-codeletion) was 78.2% (155 correctly predicted out of 198).ConclusionUsing machine-learning algorithms, high accuracy was achieved in the prediction of IDH genotype in gliomas and moderate accuracy in a three-group prediction including IDH genotype and 1p19q codeletion.
引用
收藏
页码:299 / 307
页数:9
相关论文
共 48 条
[1]
Predicting Deletion of Chromosomal Arms 1p/19q in Low-Grade Gliomas from MR Images Using Machine Intelligence [J].
Akkus, Zeynettin ;
Ali, Issa ;
Sedlar, Jiri ;
Agrawal, Jay P. ;
Parney, Ian F. ;
Giannini, Caterina ;
Erickson, Bradley J. .
JOURNAL OF DIGITAL IMAGING, 2017, 30 (04) :469-476
[2]
Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy [J].
Andronesi, Ovidiu C. ;
Kim, Grace S. ;
Gerstner, Elizabeth ;
Batchelor, Tracy ;
Tzika, Aria A. ;
Fantin, Valeria R. ;
Vander Heiden, Matthew G. ;
Sorensen, A. Gregory .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (116)
[3]
Beating the odds: extreme long-term survival with glioblastoma [J].
Bi, Wenya Linda ;
Beroukhim, Rameen .
NEURO-ONCOLOGY, 2014, 16 (09) :1159-1160
[4]
Improved Brain Tumor Classification by Sodium MR Imaging: Prediction of IDH Mutation Status and Tumor Progression [J].
Biller, A. ;
Badde, S. ;
Nagel, A. ;
Neumann, J. -O. ;
Wick, W. ;
Hertenstein, A. ;
Bendszus, M. ;
Sahm, F. ;
Benkhedah, N. ;
Kleesiek, J. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2016, 37 (01) :66-73
[5]
Impact of care at Memorial Sloan Kettering Cancer Center (MSKCC): A comprehensive cancer center on overall survival (OS) in patients (pts) with AJCC stage IV pancreas adenocarcinoma (PDAC). [J].
Boland, Fiona ;
Cheema, Ahmad ;
Lowery, Maeve Aine ;
Yu, Kenneth H. ;
Varghese, Anna M. ;
Epstein, Andrew S. ;
Abou-Alfa, Ghassan K. ;
Kelsen, David Paul ;
O'Reilly, Eileen Mary .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[6]
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas [J].
Brat, Daniel J. ;
Verhaak, Roel G. W. ;
Al-dape, Kenneth D. ;
Yung, W. K. Alfred ;
Salama, Sofie R. ;
Cooper, Lee A. D. ;
Rheinbay, Esther ;
Miller, C. Ryan ;
Vitucci, Mark ;
Morozova, Olena ;
Robertson, A. Gordon ;
Noushmehr, Houtan ;
Laird, Peter W. ;
Cherniack, Andrew D. ;
Akbani, Rehan ;
Huse, Jason T. ;
Ciriello, Giovanni ;
Poisson, Laila M. ;
Barnholtz-Sloan, Jill S. ;
Berger, Mitchel S. ;
Brennan, Cameron ;
Colen, Rivka R. ;
Colman, Howard ;
Flanders, Adam E. ;
Giannini, Caterina ;
Grifford, Mia ;
Iavarone, Antonio ;
Jain, Rajan ;
Joseph, Isaac ;
Kim, Jaegil ;
Kasaian, Katayoon ;
Mikkelsen, Tom ;
Murray, Bradley A. ;
O'Neill, Brian Patrick ;
Pachter, Lior ;
Parsons, Donald W. ;
Sougnez, Carrie ;
Sulman, Erik P. ;
Vandenberg, Scott R. ;
Van Meir, Erwin G. ;
von Deimling, Andreas ;
Zhang, Hailei ;
Crain, Daniel ;
Lau, Kevin ;
Mallery, David ;
Morris, Scott ;
Paulauskis, Joseph ;
Penny, Robert ;
Shelton, Troy ;
Sherman, Mark .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26) :2481-2498
[7]
Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[8]
The use of magnetic resonance imaging to noninvasively detect genetic signatures in oligodendroglioma [J].
Brown, Robert ;
Zlatescu, Magdalena ;
Sijben, Angeliclue ;
Roldan, Gloria ;
Easaw, Jay ;
Forsyth, Peter ;
Parney, Ian ;
Sevick, Robert ;
Yan, Elizabeth ;
Demetrick, Douglas ;
Schiff, David ;
Cairncross, Gregory ;
Mitchel, Ross .
CLINICAL CANCER RESEARCH, 2008, 14 (08) :2357-2362
[9]
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402 [J].
Cairncross, Gregory ;
Wang, Meihua ;
Shaw, Edward ;
Jenkins, Robert ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperriere, Normand ;
Curran, Walter ;
Mehta, Minesh .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) :337-343
[10]
Multimodal imaging patterns predict survival in recurrent glioblastoma patients treated with bevacizumab [J].
Chang, Ken ;
Zhang, Biqi ;
Guo, Xiaotao ;
Zong, Min ;
Rahman, Rifaquat ;
Sanchez, David ;
Winder, Nicolette ;
Reardon, David A. ;
Zhao, Binsheng ;
Wen, Patrick Y. ;
Huang, Raymond Y. .
NEURO-ONCOLOGY, 2016, 18 (12) :1680-1687